 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Radboud University Medical Center to Convert Cancer Tests to PGM, Starting with BRCA1/2 Test
February 27, 2013
Radboud University Medical Center to Convert Cancer Tests to PGM, Starting with BRCA1/2 Test
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Asuragen Launches Cancer Panels Optimized for FFPE Tissue; Plans to Sell Proprietary Reagents
April 10, 2013 / Clinical Sequencing News - New Products: Life Tech's Ion AmpliSeq Panels
April 3, 2013 / Clinical Sequencing News - At AGBT, Life Tech Updates Proton Roadmap while Users Present Data, Including Comparisons with HiSeq
February 26, 2013 / In Sequence - Oxford Group Launches PGM-Based Cancer Test under UK's Stratified Medicine Program
January 2, 2013 / Clinical Sequencing News - Life Tech to Partner with Bristol-Myers Squibb for CDx Development
September 17, 2012 / GenomeWeb Daily News